Anne-Marie Maman
Advisory Council Member @Ankh Impact Ventures
Signup · Get unlimited contacts
WORK HISTORY
Advisory Council Member @Ankh Impact Ventures
Ankh Impact Ventures invests in diverse founders driving transformative companies that benefit profitability, people, and the planet. To bridge the gender investment gap and capitalize on the proven strengths of women founders, we give significant attention to women-led businesses
EDUCATION
Northwestern University - Kellogg School of Management
MBA, Marketing, Healthcare Mgmt, Finance
Princeton University
Bachelor of Arts (BA), English Language and Literature, General
SKILLS
ABOUT ANNE-MARIE MAMAN
Senior Executive and Business Leader with US and International success in developing business strategies and roadmaps for achieving immediate and long-term objectives in M&A, startup, growth, and Fortune 500 arenas. Leverages valuable blend of business acumen, finance expertise and technical knowledge to lead product development from concept to commercialization. Skilled and highly successful in building corporate value by insightful strategic planning and by identifying, evaluating, and negotiating mergers and acquisitions of medical devices and emerging technologies. Experienced in P&L management, operations, regulatory compliance, reimbursement, and market/brand positioning. Comfortably navigates private equity and venture capital environments and enjoys the M&A process. Builds and maintains positive relationships with investors and boards of directors, as well as cross-functional teams and executive leadership.SELECTED LEADERSHIP CONTRIBUTIONS• Founded 3 startup companies, each with innovative, leading-edge technology; licensed IP, raised both non-dilutive funding and VC Funding, led all aspects of licensing and of managing the businesses, and negotiated acquisition of 1 company to a large multinational medical technology company.• Launched J&J Interventional Systems’ stenting products in European market; achieved 88% share for coronary stents and 57% share for peripheral stents, representing 70% of global JJIS business prior to US FDA product clearance.• Led US Surgical into cardiovascular market, played key role in product development, market launch and strategic planning, which helped to position US Surgical for profitable sale to Tyco.• Raised VC funding in excess of $5 million.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.